Last reviewed · How we verify
The placebo of Suxiao Jiuxin Pills
The placebo of Suxiao Jiuxin Pills is a Small molecule drug developed by Guangzhou University of Traditional Chinese Medicine. It is currently FDA-approved for Control comparator in clinical trials of Suxiao Jiuxin Pills for angina pectoris. Also known as: Con group.
A placebo formulation containing no active pharmaceutical ingredients, used as a control comparator in clinical trials of Suxiao Jiuxin Pills.
A placebo formulation containing no active pharmaceutical ingredients, used as a control comparator in clinical trials of Suxiao Jiuxin Pills. Used for Control comparator in clinical trials of Suxiao Jiuxin Pills for angina pectoris.
At a glance
| Generic name | The placebo of Suxiao Jiuxin Pills |
|---|---|
| Also known as | Con group |
| Sponsor | Guangzhou University of Traditional Chinese Medicine |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Mechanism of action
This is a placebo product designed to match the appearance and administration route of the active Suxiao Jiuxin Pills formulation while containing no therapeutic agents. It serves as a control arm in randomized controlled trials to assess the efficacy of the active traditional Chinese medicine formulation through comparison against inert treatment.
Approved indications
- Control comparator in clinical trials of Suxiao Jiuxin Pills for angina pectoris
Common side effects
Key clinical trials
- EleVation carE: a Randomized Controlled Trial on the Prevention of Acute Mountain Sickness With Suxiao Jiuxin Pill (PHASE2, PHASE3)
- Intervention of Suxiao Jiuxin Pill on Instability of Vulnerable Plaque in Acute Myocardial Infarction (PHASE4)
- Suxiao Jiuxin Pills in Microvascular Obstruction in Patients With Acute Coronary Syndrome (PHASE4)
- A Clinical Trials of Quick-Acting Heart Reliever for Moderate Coronary Stenosis (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- The placebo of Suxiao Jiuxin Pills CI brief — competitive landscape report
- The placebo of Suxiao Jiuxin Pills updates RSS · CI watch RSS
- Guangzhou University of Traditional Chinese Medicine portfolio CI
Frequently asked questions about The placebo of Suxiao Jiuxin Pills
What is The placebo of Suxiao Jiuxin Pills?
How does The placebo of Suxiao Jiuxin Pills work?
What is The placebo of Suxiao Jiuxin Pills used for?
Who makes The placebo of Suxiao Jiuxin Pills?
Is The placebo of Suxiao Jiuxin Pills also known as anything else?
What development phase is The placebo of Suxiao Jiuxin Pills in?
Related
- Manufacturer: Guangzhou University of Traditional Chinese Medicine — full pipeline
- Therapeutic area: All drugs in Cardiovascular
- Indication: Drugs for Control comparator in clinical trials of Suxiao Jiuxin Pills for angina pectoris
- Also known as: Con group
- Compare: The placebo of Suxiao Jiuxin Pills vs similar drugs
- Pricing: The placebo of Suxiao Jiuxin Pills cost, discount & access